Evogene Ltd. (TLV:EVGN)
Israel · Delayed Price · Currency is ILS · Price in ILA 365.30
+3.00 (0.83%)
At close: Nov 27, 2025
Evogene Market Cap
Evogene has a market cap or net worth of 31.84 million as of November 28, 2025. Its market cap has decreased by -16.40% in one year.
Market Cap
31.84M
Enterprise Value
40.69M
Revenue
26.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
365.30
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from 113.15M to 31.84M, a decrease of -71.86%. That is a compound annual growth rate of -6.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 27, 2025 | 31.84M | -32.76% |
| Dec 31, 2024 | 47.35M | -68.75% |
| Dec 31, 2023 | 151.55M | 64.52% |
| Dec 29, 2022 | 92.12M | -58.37% |
| Dec 30, 2021 | 221.26M | -59.72% |
| Dec 31, 2020 | 549.28M | 305.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 100.38B |
| Danel (Adir Yeoshua) | 2.73B |
| Kamada | 1.27B |
| Bait Bakfar | 1.03B |
| SofWave Medical | 1.02B |
| BrainsWay | 1.02B |
| Ilex Medical | 707.54M |
| Novolog (Pharm-Up 1966) | 664.14M |